Precision BioSciences Competitors and Similar CompaniesClear all
Precision BioSciences's competitors and similar companies include DermBiont, Jounce Therapeutics, Nouscom and Velabs Therapeutics.
 Precision BioSciences Precision BioSciences is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. |  DermBiont DermBiont develops skin microbiome therapeutics platform to treat and prevent skin diseases. |  Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
|  Velabs Therapeutics Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies. | ||
Founding Date | Founding Date 2006 | Founding Date 2017 | Founding Date 2013 | Founding Date 2015 | Founding Date N/A |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ Durham, US | Locations Boston, US HQ Emeryville, US | Locations Cambridge, US HQ | Locations Basel, CH HQ Roma, IT | Locations Heidelberg, DE HQ |
Employees | Employees 1998% increase | Employees 215% decrease | Employees 1302% increase | Employees 633% increase | Employees N/A |
Valuation ($) | Valuation ($) 60.3 m | Valuation ($) N/A | Valuation ($) 101.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($45.7m) (FY, 2025) | Net income N/A | Net income ($50.9m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 8m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 49m (over 8 years ago) | Latest funding round $ 3.4m (almost 7 years ago) |
Total funding raised | Total funding raised $ 175.2m | Total funding raised $ 8m | Total funding raised $ 103m | Total funding raised $ 62.6m | Total funding raised $ 3.4m |
For sources of this data, please see the company profile
View Company Profiles
DermBiont
HQ
Boston, US
Employees
21↓ 5% decrease
DermBiont develops skin microbiome therapeutics platform to treat and prevent skin diseases.
View company
Jounce Therapeutics
HQ
Cambridge, US
Employees
130↑ 2% increase
Jounce Therapeutics is a clinical-stage immunotherapy company.
View companyNouscom
HQ
Basel, CH
Employees
63↑ 3% increase
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View companyVelabs Therapeutics
HQ
Heidelberg, DE
Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies.
View company